Journal article

Are phosphodiesterase type 5 inhibitors potential therapies for Alzheimer’s Disease and related dementias?

Abstract:: This scientific commentary refers to ‘No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines (DREAM) study’ by Desai et al. (https://doi.org/10.1093/braincomms/fcac247) in Brain Communications.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Newby, D. (2022). Are phosphodiesterase type 5 inhibitors potential therapies for Alzheimer’s Disease and related dementias? Brain Communications, 4(5).

MLA Style

Newby, D. “Are Phosphodiesterase Type 5 Inhibitors Potential Therapies for Alzheimer’s Disease and Related Dementias?” Brain Communications, vol. 4, no. 5, Oxford University Press, 2022.

Chicago Style

Newby, D. 2022. “Are Phosphodiesterase Type 5 Inhibitors Potential Therapies for Alzheimer’s Disease and Related Dementias?” Brain Communications 4 (5).
Share
Print

Access Document

Files:: Newby_2022_Are_phosphodiesterase_type.pdf

(Preview, Version of record, pdf, 377.3KB, Terms of use)

Publisher copy:: 10.1093/braincomms/fcac260

Authors

+ Newby, D More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDORMS
Sub department:: Centre for Statistics in Medicine
Role:: Author

Publisher:: Oxford University Press
Journal:: Brain Communications More from this journal
Volume:: 4
Issue:: 5
Article number:: fcac260
Publication date:: 2022-10-11
Acceptance date:: 2022-10-02
DOI:: 10.1093/braincomms/fcac260
EISSN:: 2632-1297

Language:: English
Keywords:: FFR
Pubs id:: 1280585
Local pid:: pubs:1280585
Deposit date:: 2022-10-03

Terms of use

Copyright holder:: Newby, D
Copyright date:: 2022
Rights statement:: © The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP